BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 29340620)

  • 1. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
    Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo.
    Chen X; Tang Y; Zhang Y; Zhuo M; Tang Z; Yu Y; Zang G
    Lab Invest; 2014 May; 94(5):478-90. PubMed ID: 24614195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27-Tapasin enhances specific immune response to hepatitis B virus and inhibits viral replication in transgenic mice].
    Tang Y; Chen X; Zhou L; Zhuo M; Zang G; Tang Z; Yu Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):24-9. PubMed ID: 24721239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secretion of Th1-type cytokines and production of HBV-specific cytotoxic T lymphocytes in C57BL/6 mice induced by cytoplasmic transduction peptide-HBcAg18-27-Tapasin].
    Tang Y; Chen X; Tang Z; Zang G; Yu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):229-32. PubMed ID: 23643075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
    Song L; Zhuo M; Tang Y; Chen X; Tang Z; Zang G
    Int Immunopharmacol; 2014 Nov; 23(1):1-7. PubMed ID: 25135878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK/STAT signaling is involved in IL-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B.
    Dong Y; Li X; Yu Y; Lv F; Chen Y
    Life Sci; 2020 Jul; 252():117663. PubMed ID: 32302624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide.
    Chen X; Liu H; Tang Z; Yu Y; Zang G
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):203-12. PubMed ID: 23299079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
    Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
    Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
    Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
    Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fusion Protein of CTP-HBcAg18-27-Tapasin Mediates the Apoptosis of CD8(+)T Cells and CD8(+) T Cell Response in HLA-A2 Transgenic Mice.
    Tang YY; Tang ZH; Zhang Y; Zhuo M; Zang GQ; Chen XH; Yu YS
    Hepat Mon; 2014 Feb; 14(2):e16161. PubMed ID: 24693311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
    Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
    Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
    Wang S; Han Q; Zhang N; Chen J; Liu Z; Zhang G; Li Z
    Immunol Lett; 2010 Jan; 127(2):143-9. PubMed ID: 19883689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitinated Hepatitis D Antigen-Loaded Microvesicles Induce a Potent Specific Cellular Immune Response to Inhibit HDV Replication in Vivo.
    Yao T; Lv M; Ma S; Chen J; Zhang Y; Yu Y; Zang G; Chen X
    Microbiol Spectr; 2021 Dec; 9(3):e0102421. PubMed ID: 34908456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.
    Wang S; Yang N; Zhang L; Huang B; Tan H; Liang Y; Li Y; Yu X
    Lupus; 2010 Sep; 19(10):1171-80. PubMed ID: 20501525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].
    Li J; Han YP; Liu B; Liu Y; Chen N; Dong L; Yan YD; Jiang LF; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):38-43. PubMed ID: 21272457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.
    Sette AD; Oseroff C; Sidney J; Alexander J; Chesnut RW; Kakimi K; Guidotti LG; Chisari FV
    J Immunol; 2001 Jan; 166(2):1389-97. PubMed ID: 11145724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.
    Li L; Lei QS; Zhang SJ; Kong LN; Qin B
    PLoS One; 2016; 11(5):e0156496. PubMed ID: 27227879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.